1 2 3 4 5 6 7

PDF 16.02.2010
Creative Antibiotics' drug prevents chlamydia infection

Positive in vivo data show that Creative Antibiotics drug substance can prevent chlamydia infection. The study, which forms part of a larger project relating to sexually transmitted diseases, was performed by researchers at the University of California.
PDF 03.02.2010
Creative Antibiotics to test substances on pseudomonas bacterium

Material Transfer Agreement signed with the Univ. Cath. de Louvain (Brussels) to test Creative Antibiotics' substances on the Pseudomonas bacterium, which is potential lethal in burns patients and cause severe lung diseases in patients with COPD.
PDF 09.11.2009
Prestigious award for Neuroproofs' pain relief research

Using its pioneering screening system, Neuroproof has made an important contribution to the development of new pain relief drugs. Neuroproof receives the Polish Academy of Sciences’ Miroslaw Mossakowski Medal for the treatment of pain in advanced cancer.
PDF 01.11.2009
ARIVIS Breakthrough: Observing Living Cells in Their Three-Dimensional Environment

The "3D Tissue-Project" based on ARIVIS software engine has been succesfull in real time 3D live-cell imaging. New microscope for live-cell imaging, shows complex dynamic processes in cardiac muscle cells at an unprecedented speed.
PDF 01.11.2009
2009 Lilienthal Design-Award goes to Albutec, Wirtschaftsspiegel

Albutec wins the 2009 Lilienthal Design-Award within the Product Design cathegory competing against 62 other companies. Jury decision is based on the economic innovation impulse by the product design.
© MORE Invest GmbH & Co. KG | login